The present invention relates to substituted 1,3,8-triazaspiro[4.5]decame-2,4-diones useful as HIF prolyl hydroxylase inhibitors to treat anemia and like conditions.
-
Page/Page column 69
(2010/12/31)
More Articles about upstream products of 1258878-93-1